Back to
RA CAPITAL MANAGEMENT, L.P.
VRDNShowing 0 of 10 quarters
Position history for
RA CAPITAL MANAGEMENT, L.P.'s holdings in VIRIDIAN THERAPEUTICS INC
No. RA Capital Management exited its VRDN (Viridian Therapeutics) position in Q4 2023. Its Q3 2023 13F listed 2,007,946 shares worth $30.8M. RA Capital Management first reported VRDN in Q1 2021 and held it in 8 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of VRDN: FMR LLC